WO2003025142A3 - Nouveaux acides nucleiques et polypeptides secretes - Google Patents

Nouveaux acides nucleiques et polypeptides secretes Download PDF

Info

Publication number
WO2003025142A3
WO2003025142A3 PCT/US2002/029636 US0229636W WO03025142A3 WO 2003025142 A3 WO2003025142 A3 WO 2003025142A3 US 0229636 W US0229636 W US 0229636W WO 03025142 A3 WO03025142 A3 WO 03025142A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
novel nucleic
secreted polypeptides
novel
secreted
Prior art date
Application number
PCT/US2002/029636
Other languages
English (en)
Other versions
WO2003025142A2 (fr
Inventor
Y Tom Tang
Vinod Asundi
Ryle W Goodrich
Feiyan Ren
Jie Zhang
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Tom Wehrman
Gezhi Weng
Ping Zhou
Radoje T Drmanac
Original Assignee
Nuvelo Inc
Y Tom Tang
Vinod Asundi
Ryle W Goodrich
Feiyan Ren
Jie Zhang
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Tom Wehrman
Gezhi Weng
Ping Zhou
Radoje T Drmanac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc, Y Tom Tang, Vinod Asundi, Ryle W Goodrich, Feiyan Ren, Jie Zhang, Qing A Zhao, Jian-Rui Wang, Malabika Ghosh, Aidong J Xue, Tom Wehrman, Gezhi Weng, Ping Zhou, Radoje T Drmanac filed Critical Nuvelo Inc
Priority to AU2002343380A priority Critical patent/AU2002343380A1/en
Priority to CA002460611A priority patent/CA2460611A1/fr
Priority to EP02780320A priority patent/EP1487988A4/fr
Publication of WO2003025142A2 publication Critical patent/WO2003025142A2/fr
Publication of WO2003025142A3 publication Critical patent/WO2003025142A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouveaux acides nucléiques, de nouvelles séquences de polypeptides codées par ces acides nucléiques et les utilisations correspondantes.
PCT/US2002/029636 2001-09-16 2002-09-18 Nouveaux acides nucleiques et polypeptides secretes WO2003025142A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2002343380A AU2002343380A1 (en) 2001-09-18 2002-09-18 Novel nucleic acids and secreted polypeptides
CA002460611A CA2460611A1 (fr) 2001-09-18 2002-09-18 Nouveaux acides nucleiques et polypeptides secretes
EP02780320A EP1487988A4 (fr) 2001-09-18 2002-09-18 Nouveaux acides nucleiques et polypeptides secretes

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24581701A 2001-09-16 2001-09-16
US32334901P 2001-09-18 2001-09-18
US60/323,349 2001-09-18
US10/245,817 2002-09-16

Publications (2)

Publication Number Publication Date
WO2003025142A2 WO2003025142A2 (fr) 2003-03-27
WO2003025142A3 true WO2003025142A3 (fr) 2004-10-21

Family

ID=33161822

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/029636 WO2003025142A2 (fr) 2001-09-16 2002-09-18 Nouveaux acides nucleiques et polypeptides secretes

Country Status (1)

Country Link
WO (1) WO2003025142A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003237367A1 (en) 2002-06-03 2003-12-19 Chiron Corporation Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
DK1673475T3 (da) 2003-10-10 2010-07-19 Deutsches Krebsforsch Sammensætninger til diagnose og terapi af sygdomme, som er forbundet med aberrant ekspression af futriner (R-Spondiner) og/eller Wnt
US8119772B2 (en) * 2006-09-29 2012-02-21 California Institute Of Technology MART-1 T cell receptors
SI2081586T2 (sl) 2006-10-20 2019-01-31 Deutsches Krebsforschungszentrum, Stiftung Des Oeffentlichen Rechts Rspondini kot modulatorji angiogeneze in vaskulogeneze
WO2008099405A2 (fr) * 2007-02-15 2008-08-21 Geneswitch Innovations Llc Sécrétion de protéines de type pate
JPWO2009001555A1 (ja) * 2007-06-26 2010-08-26 国立大学法人北海道大学 Ｉ型インターフェロンの発現調節剤
AR121035A1 (es) 2019-04-01 2022-04-13 Lilly Co Eli Compuestos de neuregulina-4 y métodos de uso

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 9 October 2000 (2000-10-09), XP002979584, accession no. NCBI Database accession no. AV712481 *
See also references of EP1487988A4 *

Also Published As

Publication number Publication date
WO2003025142A2 (fr) 2003-03-27

Similar Documents

Publication Publication Date Title
WO2004009834A3 (fr) Nouveaux acides nucleiques et polypeptides secretes
WO2003054152A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003025148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002070539A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003023013A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002081731A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001075067A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057188A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057190A3 (fr) Acides nucleiques et polypeptides
WO2002022660A3 (fr) Noveaux acides nucleiques et polypeptides
WO2001066689A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002031111A3 (fr) Acides nucleiques et polypeptides
WO2001088088A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002059260A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053312A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A3 (fr) Nouveaux acides nucleiques et polypeptides associes
WO2003029271A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004080148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002018424A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO1999057132A8 (fr) Proteines secretees et polynucleotides codant pour celles-ci
WO2001079449A3 (fr) Acides nucleiques et polypeptides nouveaux
WO2003080795A3 (fr) Nouveaux acides nucléiques et polypeptides sécrétés
WO2001075068A3 (fr) Proteines secretee et polynucleotides codant pour ces proteines
WO2002081517A3 (fr) Nouveaux polypeptides et acides nucleiques codant pour ces derniers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2460611

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002780320

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002780320

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002780320

Country of ref document: EP